LivaNova (LIVN) FCF Payout Ratio (2016 - 2017)
LivaNova's (LIVN) quarterly FCF Payout Ratio came in at 0.21 in Q1 2017, down 89.3% year-on-year from 1.95 in Q1 2016, and up 2108.62% quarter-over-quarter from 0.01 in Q4 2016.
LivaNova (LIVN) FCF Payout Ratio (2016 - 2017) Analysis & Trends
LivaNova has disclosed FCF Payout Ratio across 2 years of filings, most recently posting 0.21 for Q1 2017.
- FCF Payout Ratio for Q1 2017 came in at 0.21, down 89.3% year-over-year; the trailing twelve-month figure through Mar 2017 was 0.13 (changed N/A YoY), and the FY2016 annual result was 0.12, changed N/A from the prior year.
- FCF Payout Ratio came in at 0.21 for Q1 2017 at LivaNova, up from 0.01 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 1.95 in Q1 2016 to a low of 0.01 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.20 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 0.81 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.40 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.08 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 0.25 |
| 10 | LivaNova | 4.29 Bn | 3.71 Bn | 243.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 0.21 |
| Dec 31, 2016 | -0.01 |
| Sep 30, 2016 | 0.12 |
| Mar 31, 2016 | 1.95 |